彭沙博士于日本东京农工大学获得生物医药专业博士学位，期间在中科院过程工程研究所联合培养。2025年加入GMU iCAN实验室，担任博士后研究员。他专注于疫苗佐剂与药物递送载体的研究，尤其在Pickering乳液新型疫苗佐剂的开发与应用方面具有丰富经验。目前，他主要从事可诱导抗原特异性免疫耐受的疫苗佐剂体系构建工作，该研究致力于为自身免疫性疾病的治疗提供创新性解决方案。
Dr. Sha Peng obtained her Ph.D. in Biomedical Science from Tokyo University of Agriculture and Technology, she conducted her research primarily at the Institute of Process Engineering, Chinese Academy of Sciences during this period. In 2025, she joined the GMU iCAN Lab as a Postdoctoral Research Fellow. Her expertise lies in vaccine adjuvants and drug delivery systems, with a particular focus on the development and application of Pickering emulsion-based novel vaccine adjuvants. Currently, her research centers on constructing vaccine adjuvant platforms capable of inducing antigen-specific immune tolerance, aiming to provide innovative therapeutic strategies for the treatment of autoimmune diseases.